Open-label, non-randomized, parallel-group, multicentre clinical trial to evaluate the efficacy of fingolimod as therapy for de novo vs, fingolimod patients as therapy in patients previously treated with interferons or glatiámate acetate, based on the presence of outbreaks, in patients with recurrent relapsing multiple sclerosis

Code

CFTY720DES03//2011-003484-30

Promoter

Trial Form Support, SL//Novartis Farmaceutica, S.A.

Pathology and candidate patients

Multiple sclerosis

Medical equipment

Dr. Luís Martí Bonmatí

Hospital Quirónsalud Valencia.

Study status

Active

Test product

Fingolimod

Date CEIC

January 17, 2012

CEIC

Hospital Universitario La Fe

Contact

If you are interested in this clinical trial because you believe that you or a family member of yours can benefit from this new treatment.
You can request a consultation with the image diagnosis team by sending an email to the address: info.valencia@quironsalud.es